What are the benefits and risks of methylxanthines (mild stimulant medicines) for premature babies whose breathing pauses during sleep (apnea)?

An important problem for babies who are born too early is a condition called apnea and a new Cochrane review published in October 2023 brings together the evidence on the effects of a class of drugs called methylxanthines. We asked one of the authors, Matteo Bruschettini from Cochrane Sweden, to tell us about the review ' s findings in this podcast and he used an AI voice from elevenlabs.io to make the recording.
Source: Podcasts from The Cochrane Library - Category: General Medicine Authors: Source Type: podcasts